Previous Chapter Chapter 87: Competitor Insights for Urological Devices Next Chapter
Chapter 87: Competitor Insights for Urological Devices
In 2005, the global urological device market, comprising the US, France, Germany, Italy, the United Kingdom, and Japan, was valued at $2.22 billion. Devices included in this valuation include:
- incontinence devices
- stone management devices
- benign prostatic hyperplasia (BPH) devices
- prostate cancer devices
- urological endoscopes
- erectile dysfunction (ED) devices
- ureteral access devices
- nephrostomy devices
Combined, the global urological device market will grow at over 7% annually from 2006 to 2010. Top market shareholders in the global urological device market in 2005 included American Medical Systems, Bard Urology, Boston Scientific, and Gyrus ACMI, and Mentor/Coloplast. For these companies, acquisitions have been central to offering a broader product line-up and gaining market share in recent years.
Notable trends in the global urological ...